Justia Patents Opinion Summaries

Articles Posted in US Court of Appeals for the Fourth Circuit
Plaintiff and its foreign subsidiaries (collectively, “Eli Lilly”) applied to the district court under 28 U.S.C Section 1782 for an order requiring Novartis Pharma AG to provide discovery for use in ongoing patent litigation between the two companies. After Novartis intervened and objected to Eli Lilly’s application, the district court entered an order denying the application.   The Fourth Circuit affirmed and addressed two grounds. The district court held that Novartis was not “found” in the Eastern District of Virginia because it was not physically present there. Eli Lilly contends that the court erred in interpreting the word “found” so restrictively, arguing instead that a person is “found” within a district for purposes of Section 1782 when it is “within the personal jurisdiction” of the district court, extending to “the full reach of personal jurisdiction” under the Due Process Clause.   Here, in view of the definitions in legal dictionaries and Supreme Court opinions, the court presumed that when Congress similarly used “found” in Section 1782, it intended that the same meaning apply — that a corporation is found where it is physically present by its officers and agents carrying on the corporation’s business. Thus, the district court acted in conformance with the requirements of Section 1782 when it denied Eli Lilly’s application to issue a discovery order directed against Novartis on the ground that Novartis was not found in the Eastern District of Virginia. Further, the court wrote it is apparent that the factors addressed by the district court fall squarely within those factors identified by the Supreme Court in Intel as relevant. View "Eli Lilly and Company v. Novartis Pharma AG" on Justia Law